Navigation Links
SemBioSys announces 2007 third quarter results
Date:11/1/2007

- Canadian Biotechnology Company demonstrates the technical feasibility of

a second high-value biopharmaceutical in safflower -

TSX symbol: SBS

CALGARY, Nov. 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced its 2007 third quarter operational and financial results.

Highlights

- Successfully developed commercially viable levels of both

apolipoprotein AI (Apo AI) Milano variant and, subsequent to the end

of the quarter, native Apo AI accumulation in safflower seed.

- Continued the preclinical work necessary to submit an Investigational

New Drug application (IND) to the United States Food and Drug

Administration (FDA) in early 2008 to initiate a Phase II trial for

safflower-produced insulin.

- Established Botaneco, a separate business unit dedicated to the

commercialization of SemBioSys' oilbody products for the cosmetics,

personal care and prescription topical dermatology markets.

- Commissioned the Company's commercial scale manufacturing operation

for the Botaneco business and subsequent to the end of the quarter

launched Hydresia(TM), Botaneco's first branded line of oilbody-based

ingredients.

- Obtained $2.4 million in non-dilutive development funding from AVAC

Ltd. to develop the Botaneco business, subsequent to quarter end.

- Entered into an agreement to complete a private placement financing

for total gross proceeds of approximately $9,568,000, of which

$6,500,000 was completed on a bought deal basis, subsequent to

quarter end.

- Appointed Mr. Ian S. Brown to the Board of Directors, subsequent to

quarter end. Mr. Brown is an independent businessman with ove
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... LOS ANGELES , July 6, 2015 ... the establishment of an agreement with Novella Clinical ... of ICT-107 in patients with newly diagnosed glioblastoma. Novella ... clinical trial services to small to mid-sized oncology companies. ... clinical sites in the US, Europe ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... WIEN , July 3, 2015 /PRNewswire/ ... fram till 22 september 2015 på  http://www.openinnovationinscience.at ... Open Innovation in Science" som hålls i ... Enligt en färsk undersökning med internationella forskare ... Gesellschaft (LBG) är hälsovetenskapens två största utmaningar ...
(Date:7/3/2015)... Forskere kan ansøge ... http://www.openinnovationinscience.at om efteruddannelsesprogrammet "Lab for Open ... Wien .  ... og videnskabsmænd foretaget af Ludwig Boltzmann Gesellschaft ... sundhedsvidenskaben manglen på incitamenter til at undersøge ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3
... plug-in for popular embedded tool suite. , ... ... Systems, Inc., a leading supplier of configurable and scalable real-time ... for the RTXC Quadros RTOS is now available for the ...
... in 16 Specialties, ... Hospitals Included in "Honor Roll", WASHINGTON, July 11 ... Best Hospitals, accessible,today online at http://www.usnews.com/besthospitals and on ... 2008 America,s Best Hospitals guide,ranks 170 medical centers nationwide in ...
... study using the CiTop™ technology in the coronary arteries. Ovalum ... today successful experiences using CiTop™ ExPander™ Guidewire in traversing chronic ... ... Rehovot , Israel (PRWEB) July 11, 2008 -- ...
Cached Biology Technology:RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 2RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 3RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 4U.S. News Media Group Releases 19th Edition of America's Best Hospitals 2U.S. News Media Group Releases 19th Edition of America's Best Hospitals 3Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire 2
(Date:6/24/2015)... June 24, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Sharp has selected its ... authentication for its latest flagship smartphone device, the ... 200 million shipments of its fingerprint ID sensor ... strength, scalability and leadership in the biometrics market ...
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
(Date:6/17/2015)... , and HILDEN, Germany , June ... QGEN ; Frankfurt Prime Standard: QIA) today launched new Investigator ... in forensic laboratories in the United States ... to simultaneously analyze multiple key genomic markers (short tandem repeats ... Quality Sensor to evaluate the quality of DNA in ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... stand out and attract mates, according to a new study ... Seville, Spain, and colleagues. Their research is the first to ... secretions of their uropygial gland for cosmetic reasons. The uropygial ... and is situated near the base of the tail. The ...
... may have a negative effect on Sweden,s golden eagles. ... the Swedish University of Agricultural Sciences (SLU) are trapping ... The satellite transmitters emit a signal once an ... with a picture of how the birds use the ...
... Science Applications International Corporation (SAIC) (NYSE: SAI ... contract by the U. S. Department of Defense (DoD), Biometrics ... to the U.S. Central Command,s (USCENTCOM) area of ... period of performance, two one year options and a total ...
Cached Biology News:Beauty from the bottom up 2Golden eagles studied by satellite 2SAIC Awarded $23 Million Task Order by Defense Biometrics Identity Management Agency 2
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
A powerful, easy-to-use solution, the SORVALL RC12BP Blood Processing System allows you to manufacture blood components quickly and cost-effectively while ensuring product quality, safety, and GMP co...
... a recombinant Moloney murine leukemia virus ... is similar to MuLV reverse transcriptase ... MuLV reverse transcriptase is a recombinant ... RNA as a template in the ...
Biology Products: